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How CanMicrofluidic and Microfabrication
Approaches Make Experiments More
Physiologically Relevant?Microfabricated and microfluidic devices enable standardized handling, precise spatiotemporal manipula-
tion of cells and liquids, and recapitulation of cellular environments, tissues, and organ-level biology. We
asked researchers how these devices can make in vitro experiments more physiologically relevant.Lydia L. Sohn
University of California, BerkeleyDissecting Biological Complexity
The remarkable complexity that underlies human biology results frommyriad interactions
among different cell types and signaling proteins, yielding vast biological networkswhere
spatiotemporal fluctuations between signaling nodes ultimately drive and tune biological
systems. No matter the biological context—be it to understand the immune response to
viruses, how tumors metastasize, or how stem cells respond to injury—it is clear that
a simple Petri dish falls short in capturing and interrogating the intricacies of human
biology.
A staple of the semiconductor industry, microfabrication has been widely adopted
across biology and has introduced capabilities that biologists have long desired. At
its simplest, microfabrication uses UV light to pattern arrays of high-resolution features
across different length scales—from themicroscale of single cells to themacro-scale of
a bulk tissue—all in parallel and with high throughput. This control has enabled the en-
gineered assembly of cells and proteins to create in vitro tissue models that more accu-
rately recapitulate in vivo tissuemicroenvironments. Proteins can be patterned tomimic
antagonizing signaling gradients during embryonic development, and cells can be
patterned to capture specific tissue architectures and niches. Born out of microfabrica-
tion techniques, microfluidics can add ‘‘vasculature’’ to introduce important nutrients
and soluble cues. Ultimately, microfabrication can catalyze new studies not previously
possible, leading to advances in our understanding of crucial interactions underlying
human biology and disease.Petra Schwille
Max Planck Institute of BiochemistryImprove Reproducibility!
The obvious answer to this question is that microfluidics, and microsystems tech-
nology in general, can greatly help to downsize and standardize all kinds of ex vivo
experiments, which is beneficial in many ways. But I wonder whether it is particularly
the ‘‘physiological relevance’’ that is improved by microfluidics. Even more, I am
unsure whether that is such a useful criterion altogether. What does it mean when
an experiment is physiologically relevant? That it will help to fight diseases? Or that
we actually understand biology better? As a physicist working in biology, I have found
physiological relevance to be my natural enemy, because as soon as you believe to
have understood a phenomenon, and a reviewer asks for more experiments to
make it more physiologically relevant, you can be pretty sure that you don’t under-
stand it any more afterward. Therefore, I have convinced myself that in order to
make statements about biological systems that have a longer shelf life than a couple
years, you’d better sacrifice physiological relevance for simplicity and create well-
defined and reproducible assays in which you work with purified components or
extracts whose composition you can reasonably well control. My personal dream is
to create a minimal cell bottom-up from a defined set of functional components.
Here, microsystems technology is immensely powerful for standardized handling,
but also to create 3D microenvironments that mimic the cellular habitat in scale and
shape for protein systems to unfold their functionality.Cell Systems 11, September 23, 2020 ª 2020 Published by Elsevier Inc. 209
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Microtechnology and microfabrication approaches have fueled research in biology in
the last years. With features and dimensions on the length scale of single cells, micro-
fluidic devices enable precise spatiotemporal control and manipulation of cellular
microenvironments in vitro. Parameters, such as temperature, compound concentra-
tions, flow rates, or mechanical forces, can be adjusted to reproduce—as closely as
possible—in vivo physiological conditions.
Liquid flow can be continuous or pulsatile, as it is in different biological environments,
and mechanical or biochemical cues can be tailored to mimic specific cell environ-
ments, for example, niches in which stem cells form or differentiate. Cell-cell interac-
tions that naturally occur in tissues can be realized by embedding cells in hydrogels
or by replacing traditional 2D cell cultures with 3D microtissues, which is expected to
yield more representative results in in-vitro drug testing. Even tissue-tissue interactions
can be realized by fluidically interconnecting, e.g., cancer and liver microtissues, to
recapitulate metabolic transformation effects or to mimic liver-mediated activation of
prodrugs, which greatly affect drug efficacy and/or toxicity. Moreover, microfluidic
techniques can be used to reproduce physiological compound-concentration profiles
in a human body upon oral or intravenous medication uptake.
Finally, microtechnology also includes microsensors and microelectronics, which
offer the possibility to interact with cells or tissues that react to or produce electrical
signals, most prominently heart or brain.Savas Tay
University of ChicagoControlling Space and Time
Biological systems are inherently complex and dynamic, and experiments need to capture
these features to be relevant. Tissues consist of many molecules and cell types whose
numbers, positions and configurations must be determined to understand and model
their functions. Moreover, these properties constantly change. Such dynamics is central
to processes like metabolism, immunity, development, and to many diseases. If we can
generate accurate and reproducible datasets with sufficient complexity and spatiotem-
poral resolution,wecanbuild computermodels thatwill lead to a revolution in basic biology
and medicine.
Automated microfluidics can enable this revolution. Microfluidics allows controlling
the temporal and spatial scale of experiments precisely in a very broad range, from
micrometers to centimeters, and from milliseconds to days. Using microfluidics, cells
can be pre-arranged in 2D and 3D co-cultures with predefined positions to mimic
tissues and be exposed to dynamic chemical stimuli that mimic natural signaling
systems. Dose, timing, duration, combinations and order of signaling molecules can
be precisely controlled using microfluidics.
Microfluidics improves the accuracy and reproducibility of biological measurements
by reducing pipetting errors. Moreover, parallelized microfluidic systems greatly
increase the throughput of biological experiments. Finally, combination of automated
microfluidics with closed-loop feedback control and artificial intelligence can reveal
truly autonomous experimental systems that can drive (or evolve) biological systems
to a desired outcome without human intervention.Josep Samitier
University of BarcelonaOrgans-on-Chips
Today, its envisioned that having complete control of the flows at micrometric scales
combined with cell cultures will allow the construction of systems that can mimic
complex physiological functions. The concept of ‘‘organ on a chip device’’ (OoC) that
enhances ‘‘life-like’’ environments for cell culture, aims at a better approximation of
in vivo cellular organization, function, and interactions than simple 2D tissue-culture
systems. OoC attempts to reliably reproduce the biological and physiological in vivo
characteristics, including different cell co-culture to reduce the use of animals. It is
an interesting alternative due to its versatility, controlled rapid analysis, repeatability
and low-cost design to mimic both in vivo physiological and pathological conditions.
Would OoC be able to mimic organ-level functions? The challenges facing the devel-
opment of living systems on chips are multiplied by the fact that each organ represents
its own set of challenges. The small sample volumes involved makes collecting and
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behavior are still poorly understood, and integration of multiple OoCs is in the frontier
of the present technological capabilities. Probably the evolution of dynamic control of
different media and cues for cell culture, the in situ on-chip real-time visualization of
molecular processes, the improvements of the 3D printing (and bio-printing) technolo-
gies and the use of cells from patients for personalized disease modeling would be key
issues for OoC development.Jianping Fu
University of MichiganMulticellular Microfluidics
Microengineering tools have been developed to provide new functionalities for dynamic
quantitative measurements and perturbations down to the single-cell level. These tools
have also become more widely adopted by biologists to tackle their favorite questions.
While this trend will continue, given the need tomaximize the physiological relevance of
in vitro culture systems, however, the complexity and dynamic nature of physiological
environments cannot be understated.
Microengineering tools are successful in studying cell migration and tumor angiogen-
esis and establishing human ‘‘organs-on-chips.’’ Importantly, there are exciting emerging
areas where they will make important impacts, such as multicellular development and
self-organization and developmental bioengineering. Microengineering tools are power-
ful for controlling initial seeding and positioning of single cells and cell clusters. Further-
more, microfluidics can provide local signaling centers/sources to trigger symmetry
breaking and establish dynamic signaling gradients, critical for pattern formation and
tissue morphogenesis. Microengineering tools can also allow integrated controls of
both soluble biochemical signals and insoluble biophysical cues and studying the roles
of tissue geometry and mechanical forces in influencing cell signaling and cell-cell
communication inmulticellular development. Another critical aspect formicroengineering
tools to address is scaling up to ensure their compatibility with prolonged culture and
continuous growth of multicellular structures while maintaining their unique advantages.Peter Loskill
University of T€ubingenBeyond Just Shear Forces
Combining microfabrication and tissue engineering not only leads to an unprecedented
control of structural, biochemical and mechanical parameters of the microenvironment
but also enables the creation of microfluidic channel architectures, a key aspect of
Organ-on-Chip technology. These channels feature similar dimensions as the human
microvasculature and allow for a perfusion of tissue constructs with ‘‘blood surrogates.’’
Often-discussed facets of perfusion are shear forces and their effect on cell morphology
and functionality. However, the impact of microfluidic perfusion on the physiological rele-
vance goes far beyond this aspect as it, e.g., allows for physiological cell-to-media ratios
and vasculature-like transportation processes. Physiological cell-to-media ratios ensure
that cells are at any time in contact only with a small media volume preventing dilution of
secreted factors important for autocrine and paracrine signaling. Vasculature-like trans-
portation processes enable the generation of precisely controllable (stable) conditions,
a continuous delivery of fresh nutrients at physiological levels, and a removal ofmetabolic
products. In contrast, in conventional static culture, a significant portion of nutrients is
consumed already after two days, depending on the metabolic activity of the cells. At
the same time, there is a continuous buildup of secreted factors and metabolic (waste)
products. This means that culture conditions vary continuously, initial nutrient levels
have to be at non-physiological high levels and periodic media exchanges create non-
physiological rhythms and artificial dynamics.Cell Systems 11, September 23, 2020 211
